Skip to search formSkip to main contentSkip to account menu

ON 01910

Known as: ON-01910, ON01910 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

GlycineSulfones

Narrower (2)

ON 01910.Narigosertib
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer
IntroductionOvarian cancer is a difficult to treat cancer entity with a high relapse rate. After initial surgery and chemotherapy… 
2011
2011
Application of a liquid chromatography-tandem mass spectrometry (LC/MS/MS) method to the pharmacokinetics of ON01910 in brain tumor-bearing mice.
2010
2010
Abstract 3493: ON 01910. Na, a clinical trial stage multi-kinase inhibitor, induces apoptosis in chronic lymphocytic leukemia (CLL) cells through inhibition of PI3K/AKT and activation of the JNK…
Chronic Lymphocytic leukemia (CLL), the most common leukemia in Western countries, is a clinically heterogeneous disease… 
Review
2009
Review
2009
BI 6727 , APolo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad
Purpose:Antimitotic chemotherapy remains a cornerstone of multimodality treatment for locally advanced andmetastatic cancers.To… 
2008
2008
ON01910. Na enhances chemotherapeutic agents active in drug resistant tumors
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)